Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ophiopogon japonicus is a perennial herb native to East Asia and widely used in traditional Chinese medicine (TCM) under the name Mai Men Dong. The medicinal part is the root tuber (Ophiopogonis Radix), which contains bioactive compounds such as steroidal saponins, homoisoflavonoids, polysaccharides, and plant sterols like beta-sitosterol. Traditionally prescribed for over two thousand years in China and Japan, it is used to nourish yin, moisten the lungs and stomach, promote body fluid production, ease the mind (calm anxiety), clear heart fire (reduce inflammation), relieve dry coughs and throat irritation, treat insomnia and palpitations. Modern pharmacological studies have demonstrated anti-inflammatory effects via inhibition of pro-inflammatory cytokines (e.g., IL-1β and IL-6) through MAPK pathway modulation; antioxidant activity; cardiovascular protection by reducing oxidative stress; immunomodulation; anticancer potential; antimicrobial action against bacteria such as Staphylococcus aureus and E. coli; antidiabetic effects; cough relief; skin barrier repair with moisturizing properties for dermatological use including atopic dermatitis[2][4][5][7][9]. It is also considered a functional food ingredient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ophiopogon japonicus.